Phase II Trials for Drug Licensing: Analysis Shows That Efficacy Is Often Overestimated
Phase II drug trials systematically overestimate the efficacy of therapeutics, so that subsequent phase III trials often produce disappointing results.
Read MoreSearch Results for: covid-19
Long-Term Care Needs More Testing to Protect Residents and Save Lives
It is time to rally around nursing home and assisted-living residents the same way we have around hospital patients and workers.
Read MoreNew Qnostics SARS-CoV-2 Control
The Qnostics SARS-CoV-2 Medium Q control is designed to ensure the accuracy and reliability of molecular assays used in diagnostic testing for covid-19.
Read MoreRecombinant SARS-CoV-2 Nucleocapsid Protein for Diagnostic Testing
The new recombinant SARS-CoV-2 nucleocapsid protein is for covid-19 diagnostic test manufacturers, vaccine developers, and researchers globally.
Read More
FDA Authorizes Rutgers Saliva Test for Coronavirus
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read More